Other plasma cell disorders

Dr. Jonathan Kaufman is the Medical Director of the Winship Cancer Institute Ambulatory Infusion Centers at the Emory University School of Medicine. He is also…

Craig C. Hofmeister, MD, MPH

Craig C. Hofmeister is Associate Professor, Department of Hematology and Medical Oncology at Emory University School of Medicine. Board certified in internal…

Sham Mailankody, MBBS

Robert A. Kyle, MD

Robert A. Kyle is a Hematology specialist and Professor of Laboratory Medicine and Pathology at Mayo Clinicexternal link, opens in a new tab, Rochester, Minnesota.…

Francis K. Buadi, MD

Dr. Francis K. Buadi is a Hematologist and an Internist at Mayo Clinicexternal link, opens in a new tab, Minnesota. He completed his Residency in Internal Medicine…

Wilson I. Gonsalves, MD

Wilson I. Gonsalves is a graduate from Creighton University and has also obtained a degree in medicine from Creighton University School of Medicine. He obtained…

Subscribe to

Newsletter

Expert and Community Perspectives on Attruby®

In this special session, Dr. Barry Trachtenberg and members of the ATTR amyloidosis community came together to share medical insights and lived experiences related to Attruby™ (acoramidis). This expert-led discussion explores the clinical data, the patient perspective, and what lies ahead for those considering or currently taking Attruby.